cannabinoids
Cannabinoids are several structural classes of compounds found primarily in the Cannabis plant or as synthetic compounds. The most notable cannabinoid is the phytocannabinoid tetrahydrocannabinol (THC) (delta-9-THC), the primary psychoactive compound in cannabis. Cannabidiol (CBD) is also a major constituent of temperate cannabis plants and a minor constituent in tropical varieties. At least 100 distinct phytocannabinoids have been isolated from cannabis, although only four have been demonstrated to have a biogenetic origin. It was reported in 2020 that phytocannabinoids can be found in other plants such as rhododendron, licorice and liverwort, and earlier in Echinacea. — Wikipedia
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Earliest trial started Jul 31, 2019 (NCT03782402)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCannabinoid ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05985850 | Phase 2 | Jan 31, 2024 | BC Centre on Substance Use, Canadian Institutes of Health Research (CIHR), University of British Columbia |
| NCT05026164 | Phase 2 | Sep 6, 2021 | Canopy Growth Corporation |
| NCT03782402 | Phase 2 | Jul 31, 2019 | Columbia University |
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BC Centre on Substance Use | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Canadian Institutes of Health Research (CIHR) | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Canopy Growth Corporation | For profit | 1 | 1 | 1 | 2021 |
| Columbia University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of British Columbia | Academic/Hospital | 1 | 0 | 1 | 2024 |